;PMID: 8843915
;source_file_1309.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..49] = [t:0..49]
;1)sentence:[e:54..125] = [t:54..125]
;2)section:[e:129..184] = [t:129..184]
;3)section:[e:188..289] = [t:188..289]
;4)sentence:[e:293..301] = [t:293..301]
;5)sentence:[e:302..468] = [t:302..468]
;6)sentence:[e:469..477] = [t:469..477]
;7)sentence:[e:478..562] = [t:478..562]
;8)sentence:[e:563..729] = [t:563..729]
;9)sentence:[e:730..856] = [t:730..856]
;10)sentence:[e:857..865] = [t:857..865]
;11)sentence:[e:866..966] = [t:866..966]
;12)sentence:[e:967..1064] = [t:967..1064]
;13)sentence:[e:1065..1209] = [t:1065..1209]
;14)sentence:[e:1211..1301] = [t:1211..1301]
;15)sentence:[e:1302..1314] = [t:1302..1314]
;16)sentence:[e:1315..1436] = [t:1315..1436]
;17)sentence:[e:1437..1537] = [t:1437..1537]
;18)sentence:[e:1538..1650] = [t:1538..1650]
;19)sentence:[e:1651..1758] = [t:1651..1758]
;20)section:[e:1762..1806] = [t:1762..1806]

;section 0 Span:0..49
;Invest Ophthalmol Vis Sci  1996 Oct;37(11):2313-7
(SEC
  (FRAG (NNP:[0..6] Invest) (NNP:[7..17] Ophthalmol) (NNP:[18..21] Vis)
        (NNP:[22..25] Sci) (CD:[27..31] 1996) (.:[32..38] Oct;37)
        (-LRB-:[38..39] -LRB-) (CD:[39..41] 11) (-RRB-:[41..42] -RRB-)
        (::[42..43] :) (CD:[43..49] 2313-7)))

;sentence 1 Span:54..125
;Identification of mutations in the Ki-ras gene in human retinoblastoma.
;[89..95]:gene-rna:"Ki-ras"
;[110..124]:malignancy-type:"retinoblastoma"
(SENT
  (NP-HLN
    (NP (NN:[54..68] Identification))
    (PP (IN:[69..71] of)
      (NP
        (NP (NNS:[72..81] mutations))
        (PP-LOC (IN:[82..84] in)
          (NP (DT:[85..88] the) (NN:[89..95] Ki-ras) (NN:[96..100] gene)))))
    (PP (IN:[101..103] in)
      (NP (JJ:[104..109] human) (NN:[110..124] retinoblastoma)))
    (.:[124..125] .)))

;section 2 Span:129..184
;Bautista D, Emanuel JR, Granville C, Howard R, Costa J.
(SEC
  (FRAG (NNP:[129..137] Bautista) (NNP:[138..139] D) (,:[139..140] ,)
        (NNP:[141..148] Emanuel) (NNP:[149..151] JR) (,:[151..152] ,)
        (NNP:[153..162] Granville) (NNP:[163..164] C) (,:[164..165] ,)
        (NNP:[166..172] Howard) (NNP:[173..174] R) (,:[174..175] ,)
        (NNP:[176..181] Costa) (NNP:[182..184] J.)))

;section 3 Span:188..289
;Department of Pathology, Yale University School of Medicine, New Haven, 
;Connecticut 06520-8023, USA.
(SEC
  (FRAG (NNP:[188..198] Department) (IN:[199..201] of)
        (NNP:[202..211] Pathology) (,:[211..212] ,) (NNP:[213..217] Yale)
        (NNP:[218..228] University) (NNP:[229..235] School) (IN:[236..238] of)
        (NNP:[239..247] Medicine) (,:[247..248] ,) (NNP:[249..252] New)
        (NNP:[253..258] Haven) (,:[258..259] ,) (NNP:[261..272] Connecticut)
        (CD:[273..278] 06520) (HYPH:[278..279] -) (CD:[279..283] 8023)
        (,:[283..284] ,) (NNP:[285..288] USA) (.:[288..289] .)))

;sentence 4 Span:293..301
;PURPOSE:
(SENT
  (NP (NN:[293..300] PURPOSE) (::[300..301] :)))

;sentence 5 Span:302..468
;To investigate the mutational status of the Ki-ras gene in  retinoblastoma
;and to evaluate a correlation of the genotype with clinical and 
;histopathologic variables.
;[346..352]:gene-rna:"Ki-ras"
;[362..376]:malignancy-type:"retinoblastoma"
(SENT
  (S
    (NP-SBJ (-NONE-:[302..302] *))
    (VP
      (VP (TO:[302..304] To)
        (VP (VB:[305..316] investigate)
          (NP
            (NP (DT:[317..320] the) (JJ:[321..331] mutational)
                (NN:[332..338] status))
            (PP (IN:[339..341] of)
              (NP (DT:[342..345] the) (NN:[346..352] Ki-ras)
                  (NN:[353..357] gene))))
          (PP (IN:[358..360] in)
            (NP (NN:[362..376] retinoblastoma)))))
      (CC:[377..380] and)
      (VP (TO:[381..383] to)
        (VP (VB:[384..392] evaluate)
          (NP
            (NP (DT:[393..394] a) (NN:[395..406] correlation))
            (PP (IN:[407..409] of)
              (NP (DT:[410..413] the) (NN:[414..422] genotype)))
            (PP (IN:[423..427] with)
              (NP
                (ADJP (JJ:[428..436] clinical) (CC:[437..440] and)
                      (JJ:[442..457] histopathologic))
                (NNS:[458..467] variables)))))))
    (.:[467..468] .)))

;sentence 6 Span:469..477
;METHODS:
(SENT
  (NP (NNS:[469..476] METHODS) (::[476..477] :)))

;sentence 7 Span:478..562
;Tumor samples were microdissected from  sectioned archival paraffin-embedded
;tissue.
(SENT
  (S
    (NP-SBJ-1 (NN:[478..483] Tumor) (NNS:[484..491] samples))
    (VP (VBD:[492..496] were)
      (VP (VBN:[497..511] microdissected)
        (NP-1 (-NONE-:[511..511] *))
        (PP (IN:[512..516] from)
          (NP (VBN:[518..527] sectioned) (JJ:[528..536] archival)
            (ADJP (NN:[537..545] paraffin) (HYPH:[545..546] -)
                  (VBN:[546..554] embedded))
            (NN:[555..561] tissue)))))
    (.:[561..562] .)))

;sentence 8 Span:563..729
;Ki-ras genomic sequences (exons 1  and 2) were amplified by polymerase chain
;reaction then analyzed by  single-strand conformation polymorphism and direct
;sequencing.
;[563..569]:gene-rna:"Ki-ras"
;[589..596]:variation-location:"exons 1"
;[589..594]...[602..603]:variation-location:"exons"..."2"
;[623..633]:gene-protein:"polymerase"
(SENT
  (S
    (NP-SBJ-2 (NN:[563..569] Ki-ras) (JJ:[570..577] genomic)
              (NNS:[578..587] sequences)
      (PRN (-LRB-:[588..589] -LRB-)
        (NP
          (NP
            (NML-1 (NNS:[589..594] exons))
            (CD:[595..596] 1))
          (CC:[598..601] and)
          (NP
            (NML-1 (-NONE-:[601..601] *P*))
            (CD:[602..603] 2)))
        (-RRB-:[603..604] -RRB-)))
    (VP (VBD:[605..609] were)
      (VP
        (VP (VBN:[610..619] amplified)
          (NP-2 (-NONE-:[619..619] *))
          (PP-MNR (IN:[620..622] by)
            (NP (NN:[623..633] polymerase) (NN:[634..639] chain)
                (NN:[640..648] reaction))))
        (VP
          (ADVP-TMP (RB:[649..653] then))
          (VBN:[654..662] analyzed)
          (NP-2 (-NONE-:[662..662] *))
          (PP-MNR (IN:[663..665] by)
            (NP
              (NP
                (NML (JJ:[667..673] single) (HYPH:[673..674] -)
                     (NN:[674..680] strand))
                (NN:[681..693] conformation) (NN:[694..706] polymorphism))
              (CC:[707..710] and)
              (NP (JJ:[711..717] direct) (NN:[718..728] sequencing)))))))
    (.:[728..729] .)))

;sentence 9 Span:730..856
;Tissue sections,  flanking the analyzed samples, were stained with
;hematoxylin and eosin for  examination by light microscopy.
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[730..736] Tissue) (NNS:[737..745] sections))
      (,:[745..746] ,)
      (VP (VBG:[748..756] flanking)
        (NP (DT:[757..760] the) (VBN:[761..769] analyzed)
            (NNS:[770..777] samples))))
    (,:[777..778] ,)
    (VP (VBD:[779..783] were)
      (VP (VBN:[784..791] stained)
        (NP-1 (-NONE-:[791..791] *))
        (PP (IN:[792..796] with)
          (NP (NN:[797..808] hematoxylin) (CC:[809..812] and)
              (NN:[813..818] eosin)))
        (PP (IN:[819..822] for)
          (NP
            (NP (NN:[824..835] examination))
            (PP (IN:[836..838] by)
              (NP (NN:[839..844] light) (NN:[845..855] microscopy)))))))
    (.:[855..856] .)))

;sentence 10 Span:857..865
;RESULTS:
(SENT
  (NP (NNS:[857..864] RESULTS) (::[864..865] :)))

;sentence 11 Span:866..966
;Four of 12 tumors had mutation in exon  1, codon 12 of the Ki-ras gene; none
;had mutation in exon 2.
;[888..896]:variation-event:"mutation"
;[900..907]:variation-location:"exon  1"
;[909..917]:variation-location:"codon 12"
;[925..931]:gene-rna:"Ki-ras"
;[947..955]:variation-event:"mutation"
;[959..965]:variation-location:"exon 2"
(SENT
  (S
    (S
      (NP-SBJ
        (NP (CD:[866..870] Four))
        (PP (IN:[871..873] of)
          (NP (CD:[874..876] 12) (NNS:[877..883] tumors))))
      (VP (VBD:[884..887] had)
        (NP (NN:[888..896] mutation))
        (PP-LOC (IN:[897..899] in)
          (NP
            (NP (NN:[900..904] exon) (CD:[906..907] 1))
            (,:[907..908] ,)
            (NP (NN:[909..914] codon) (CD:[915..917] 12))
            (PP (IN:[918..920] of)
              (NP (DT:[921..924] the) (NN:[925..931] Ki-ras)
                  (NN:[932..936] gene)))))))
    (::[936..937] ;)
    (S
      (NP-SBJ (NN:[938..942] none))
      (VP (VBD:[943..946] had)
        (NP (NN:[947..955] mutation))
        (PP-LOC (IN:[956..958] in)
          (NP (NN:[959..963] exon) (CD:[964..965] 2)))))
    (.:[965..966] .)))

;sentence 12 Span:967..1064
;Signal intensity of  the mutated alleles indicates clonal mutation in the
;tumor cell populations.
(SENT
  (S
    (NP-SBJ
      (NP (NN:[967..973] Signal) (NN:[974..983] intensity))
      (PP (IN:[984..986] of)
        (NP (DT:[988..991] the) (VBN:[992..999] mutated)
            (NNS:[1000..1007] alleles))))
    (VP (VBZ:[1008..1017] indicates)
      (NP (JJ:[1018..1024] clonal) (NN:[1025..1033] mutation))
      (PP (IN:[1034..1036] in)
        (NP (DT:[1037..1040] the) (NN:[1041..1046] tumor) (NN:[1047..1051] cell)
            (NNS:[1052..1063] populations))))
    (.:[1063..1064] .)))

;sentence 13 Span:1065..1209
;One  of four bilateral tumors was mutated, and all three samples with 
;undifferentiated histologic appearance harbored a clonal Ki-ras mutation.
;[1078..1094]:malignancy-type:"bilateral tumors"
;[1193..1199]:gene-rna:"Ki-ras"
(SENT
  (S
    (S
      (NP-SBJ-1
        (NP (CD:[1065..1068] One))
        (PP (IN:[1070..1072] of)
          (NP (CD:[1073..1077] four)
             (JJ:[1078..1087] bilateral) (NNS:[1088..1094] tumors))))
      (VP (VBD:[1095..1098] was)
        (VP (VBN:[1099..1106] mutated)
          (NP-1 (-NONE-:[1106..1106] *)))))
    (,:[1106..1107] ,) (CC:[1108..1111] and)
    (S
      (NP-SBJ
        (NP (DT:[1112..1115] all) (CD:[1116..1121] three)
            (NNS:[1122..1129] samples))
        (PP (IN:[1130..1134] with)
          (NP (JJ:[1136..1152] undifferentiated) (JJ:[1153..1163] histologic)
              (NN:[1164..1174] appearance))))
      (VP (VBD:[1175..1183] harbored)
        (NP (DT:[1184..1185] a) (JJ:[1186..1192] clonal)
            (NN:[1193..1199] Ki-ras) (NN:[1200..1208] mutation))))
    (.:[1208..1209] .)))

;sentence 14 Span:1211..1301
;However, only one of nine moderately to poorly differentiated tumors harbored
;a  mutation.
(SENT
  (S
    (ADVP (RB:[1211..1218] However))
    (,:[1218..1219] ,)
    (NP-SBJ
      (NP (RB:[1220..1224] only) (CD:[1225..1228] one))
      (PP (IN:[1229..1231] of)
        (NP (CD:[1232..1236] nine)
          (ADJP
            (ADVP (RB:[1237..1247] moderately) (TO:[1248..1250] to)
                  (RB:[1251..1257] poorly))
            (VBN:[1258..1272] differentiated))
          (NNS:[1273..1279] tumors))))
    (VP (VBD:[1280..1288] harbored)
      (NP (DT:[1289..1290] a) (NN:[1292..1300] mutation)))
    (.:[1300..1301] .)))

;sentence 15 Span:1302..1314
;CONCLUSIONS:
(SENT
  (NP (NNS:[1302..1313] CONCLUSIONS) (::[1313..1314] :)))

;sentence 16 Span:1315..1436
;Ki-ras, an oncogene seldom altered in neuroectodermal  neoplasms, is mutated
;in one third of the retinoblastomas studied.
;[1315..1321]:gene-rna:"Ki-ras"
;[1353..1379]:malignancy-type:"neuroectodermal  neoplasms"
;[1412..1427]:malignancy-type:"retinoblastomas"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[1315..1321] Ki-ras))
      (,:[1321..1322] ,)
      (NP
        (NP (DT:[1323..1325] an) (NN:[1326..1334] oncogene))
        (VP
          (ADVP-TMP (RB:[1335..1341] seldom))
          (VBN:[1342..1349] altered)
          (NP (-NONE-:[1349..1349] *))
          (PP-LOC (IN:[1350..1352] in)
            (NP (JJ:[1353..1368] neuroectodermal) (NNS:[1370..1379] neoplasms))))))
    (,:[1379..1380] ,)
    (VP (VBZ:[1381..1383] is)
      (VP (VBN:[1384..1391] mutated)
        (NP-1 (-NONE-:[1391..1391] *))
        (PP (IN:[1392..1394] in)
          (NP
            (NP (CD:[1395..1398] one) (NN:[1399..1404] third))
            (PP (IN:[1405..1407] of)
              (NP
                (NP (DT:[1408..1411] the) (NNS:[1412..1427] retinoblastomas))
                (VP (VBN:[1428..1435] studied)
                  (NP (-NONE-:[1435..1435] *)))))))))
    (.:[1435..1436] .)))

;sentence 17 Span:1437..1537
;The Ki-ras  mutations are clonal, suggesting that affected cells have a
;selective growth  advantage.
;[1441..1447]:gene-rna:"Ki-ras"
;[1449..1458]:variation-event:"mutations"
(SENT
  (S
    (NP-SBJ (DT:[1437..1440] The) (NN:[1441..1447] Ki-ras)
            (NNS:[1449..1458] mutations))
    (VP (VBP:[1459..1462] are)
      (ADJP-PRD (JJ:[1463..1469] clonal))
      (,:[1469..1470] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1470..1470] *))
        (VP (VBG:[1471..1481] suggesting)
          (SBAR (IN:[1482..1486] that)
            (S
              (NP-SBJ (VBN:[1487..1495] affected) (NNS:[1496..1501] cells))
              (VP (VBP:[1502..1506] have)
                (NP (DT:[1507..1508] a) (JJ:[1509..1518] selective)
                    (NN:[1519..1525] growth) (NN:[1527..1536] advantage))))))))
    (.:[1536..1537] .)))

;sentence 18 Span:1538..1650
;The mutations are present and are likely to play a pathogenetic role  in
;heritable and sporadic retinoblastomas.
;[1542..1551]:variation-event:"mutations"
;[1634..1649]:malignancy-type:"retinoblastomas"
(SENT
  (S
    (NP-SBJ-1 (DT:[1538..1541] The) (NNS:[1542..1551] mutations))
    (VP
      (VP (VBP:[1552..1555] are)
        (ADJP-PRD (JJ:[1556..1563] present)))
      (CC:[1564..1567] and)
      (VP (VBP:[1568..1571] are)
        (ADJP-PRD (JJ:[1572..1578] likely)
          (S
            (NP-SBJ-1 (-NONE-:[1578..1578] *))
            (VP (TO:[1579..1581] to)
              (VP (VB:[1582..1586] play)
                (NP (DT:[1587..1588] a) (JJ:[1589..1601] pathogenetic)
                    (NN:[1602..1606] role))
                (PP (IN:[1608..1610] in)
                  (NP
                    (NP (JJ:[1611..1620] heritable)
                      (NML-2 (-NONE-:[1620..1620] *P*)))
                    (CC:[1621..1624] and)
                    (NP (JJ:[1625..1633] sporadic)
                      (NML-2 (NNS:[1634..1649] retinoblastomas)))))))))))
    (.:[1649..1650] .)))

;sentence 19 Span:1651..1758
;These results suggest that mutations  in Ki-ras are preferentially associated
;with undifferentiated tumors.
;[1692..1698]:gene-rna:"Ki-ras"
(SENT
  (S
    (NP-SBJ (DT:[1651..1656] These) (NNS:[1657..1664] results))
    (VP (VBP:[1665..1672] suggest)
      (SBAR (IN:[1673..1677] that)
        (S
          (NP-SBJ-1
            (NP (NNS:[1678..1687] mutations))
            (PP-LOC (IN:[1689..1691] in)
              (NP (NN:[1692..1698] Ki-ras))))
          (VP (VBP:[1699..1702] are)
            (ADVP (RB:[1703..1717] preferentially))
            (VP (VBN:[1718..1728] associated)
              (NP-1 (-NONE-:[1728..1728] *))
              (PP-CLR (IN:[1729..1733] with)
                (NP (JJ:[1734..1750] undifferentiated) (NNS:[1751..1757] tumors))))))))
    (.:[1757..1758] .)))

;section 20 Span:1762..1806
;PMID: 8843915 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1762..1766] PMID) (::[1766..1767] :) (CD:[1768..1775] 8843915)
        (NN:[1776..1777] -LSB-) (NNP:[1777..1783] PubMed) (::[1784..1785] -)
        (NN:[1786..1793] indexed) (IN:[1794..1797] for)
        (NNP:[1798..1806] MEDLINE-RSB-)))
